CoreCap Advisors’s NeoGenomics NEO Stock Holding History

CoreCap Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-217	Closed	-$2K	–	1513
2022 Q2	$2K	Buy	+217	New	+$2.07K	﹤0.01%	1884
2022 Q1	–	Sell	-217	Closed	-$7K	–	1501
2021 Q4	$7K	Buy	+217	New	+$8.5K	﹤0.01%	1667

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CoreCap Advisors's NEO Position: Q3 2022 in Review

CoreCap Advisors sold out of NeoGenomics (NEO) in Q3 2022, closing a stake of 217 shares — an estimated $2K sold.

CoreCap Advisors first reported a position in NEO in Q4 2021 and held it in 2 quarters. The position peaked at $7K in Q4 2021. 245 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

CoreCap Advisors reported no remaining NeoGenomics position as of Q3 2022 after selling out during the quarter.
CoreCap Advisors sold 217 NeoGenomics shares in Q3 2022, an estimated $2K.
CoreCap Advisors first reported a position in NeoGenomics in Q4 2021 and held it in 2 quarters.
CoreCap Advisors's NeoGenomics position peaked at $7K in Q4 2021.
245 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on CoreCap Advisors's 13F filing for Q3 2022, filed 10 Feb 2023.